Andy Karabajakian Selected Research

Andy Karabajakian Research Topics

10	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2017
6	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2017
5	Neoplasms (Cancer) 01/2024 - 05/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 10/2022
2	Lung Neoplasms (Lung Cancer) 10/2022 - 10/2022
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2018 - 01/2017
1	Adenosarcoma 07/2023
1	Tertiary Lymphoid Structures 01/2021

5	Immune Checkpoint InhibitorsIBA 01/2024 - 05/2020
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2021
2	Cetuximab (Erbitux)FDA Link 10/2022 - 04/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 04/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2018
1	LigandsIBA 01/2024
1	Hormones (Hormone)IBA 07/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2023
1	Estrogen ReceptorsIBA 07/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2023
1	trametinibIBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 04/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2018
1	NivolumabIBA 03/2018